SC 13G/A





Washington, D.C. 20549




Under the Securities Exchange Act of 1934

(Amendment No. 4)*



ASML Holding N.V.

(Name of Issuer)

Ordinary Shares

(Title of Class of Securities)


(CUSIP Number)

December 31, 2018

(Date of Event Which Requires Filing of this Statement)



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)



The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”), or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).





Page 1 of 5

CUSIP No. 5949368



Names of Reporting Persons

I.R.S. Identification No. of Above Persons (Entities Only)


Intel Corporation



Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ☐        

(b)  ☐



SEC Use Only



Citizenship or Place of Organization



Number of   



Owned by   






Sole Voting Power




Shared Voting Power




Sole Dispositive Power




Shared Dispositive Power




Aggregate Amount Beneficially Owned by Each Reporting Person




Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ☐



Percent of Class Represented by Amount in Row (9)*




Type of Reporting Person (See Instructions)





See Item 4 below.


Page 2 of 5

Item 1.      

Name of Issuer

ASML Holding N.V.


Address of Issuer’s Principal Executive Offices

De Run 6501

5504 DR, Veldhoven

The Netherlands

Item 2.      

Name of Person(s) Filing

Intel Corporation


Address of Principal Business Office or, if none, Residence

2200 Mission College Boulevard

Santa Clara, California 95054-1549





Title of Class of Securities

Ordinary Shares


CUSIP Number



Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable


Page 3 of 5

Item 4.


Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a), (b), and (c)


Reporting Persons

   Number of Shares
With Sole Voting and
Dispositive Power
     Number of Shares
With Shared Voting
and Dispositive Power
     Aggregate Number
of Shares
Beneficially Owned
     Percentage of
Class Beneficially

Intel Corporation

     0        6,936,055      6,936,055        1.6



Represents ordinary shares of the Issuer directly held by Intel Holdings B.V., a wholly-owned subsidiary of the Reporting Person (“Intel Holdings B.V.”), which are deemed to be beneficially owned by the Reporting Person. The Reporting Person does not directly hold any shares of the Issuer. By reason of the provisions of Rule 13d-3 under the Act, the Reporting Person is deemed to own beneficially the ordinary shares of the Issuer directly held by Intel Holdings B.V.


Based upon 421,097,729 ordinary shares of the Issuer outstanding as of December 31, 2018 as disclosed in the Form 20-F filed by the Issuer with the Securities and Exchange Commission on February 6, 2019.


Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ☒.


Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not applicable.


Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not applicable.


Item 8.

Identification and Classification of Members of the Group

Not applicable.


Item 9.

Notice of Dissolution of Group

Not applicable.


Item 10.


By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


Page 4 of 5


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated as of February 12, 2019


By:   /s/ Susie Giordano
Name:   Susie Giordano
Title:   Corporate Vice President and Corporate Secretary



The undersigned hereby constitutes and appoints Susie Giordano and Allon Stabinsky, and with full power of substitution, the undersigned’s true and lawful attorney-in-fact with full power to execute and file with the Securities and Exchange Commission and any stock exchange or similar authority, any report required to be filed pursuant to Section 13 of the Securities Exchange Act of 1934 (as amended, the “Act”), with respect to securities which may be deemed to be beneficially owned by the Company under the Act, giving and granting unto said attorney-in-fact the power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof.

This Power of Attorney shall remain in full force and effect until either revoked in writing by the undersigned or until such time as the person to whom power of attorney has been hereby granted ceases to be an employee of Intel Corporation.

The undersigned has caused this Power of Attorney to be executed as of February 12, 2019.


By:   /s/ Robert H. Swan

Robert H. Swan

Chief Executive Officer


Page 5 of 5